93578
Poly(L-lactide)
viscosity ~1.0 dL/g, 0.1 % (w/v) in chloroform(25 °C)
Synonym(s):
L-Lactide polymer, PLA, Poly(L-Lactic acid)
Select a Size
$624.00
$624.00
About This Item
Skip To
Product Name
Poly(L-lactide), viscosity ~1.0 dL/g, 0.1 % (w/v) in chloroform(25 °C)
description
ester terminated
form
solid
mol wt
Mn 59,000
Mw 101,000
degradation timeframe
>3 years
impurities
<0.5% water
viscosity
~1.0 dL/g, 0.1 % (w/v) in chloroform(25 °C)
Mw/Mn
<1.8
Quality Level
Looking for similar products? Visit Product Comparison Guide
Related Categories
1 of 4
This Item | 81273 | 95468 | 94829 |
|---|---|---|---|
| form solid | form solid | form solid | form solid |
| impurities <0.5% water | impurities ≤0.5% water | impurities <0.5% water | impurities - |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| description ester terminated | description ester terminated | description ester terminated | description ester terminated |
| mol wt Mn 59,000 | mol wt Mw ~260,000 | mol wt Mn 103,000, Mw 259,000 | mol wt average Mn 40,000 |
| degradation timeframe >3 years | degradation timeframe >3 years | degradation timeframe >3 years | degradation timeframe >3 years |
Application
Other Notes
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
In the past two decades, tissue engineering and regenerative medicine have become important interdisciplinary fields that span biology, chemistry, engineering, and medicine.
AliAliphatic polyesters, including polylactide and polyglycolide, are biodegradable polymers widely used in medical applications.
Interest in utilizing biodegradable polymers for biomedical applications has grown since the 1960s.
Immunosuppressive tumor-associated myeloid cells (TAMC) are responsible for glioblastoma (GBM) resistance to immunotherapies and existing standard of care treatments. This mini-review highlights recent progress in implementing nanotechnology in advancing TAMC-targeted therapies for GBM.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service